Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Mol Immunol. 2009 Feb;46(5):991-8. doi: 10.1016/j.molimm.2008.09.034. Epub 2008 Nov 18.

C-mip interacts physically with RelA and inhibits nuclear factor kappa B activity.

Author information

  • 1INSERM, U 841, Créteil 94010, France; Institut Mondor de Recherche Biomédicale (IMRB), Département "génétique", Equipe "21", Créteil, F-94010, France.

Abstract

The fine regulation of NF-kappaB activity is crucial for both resting and stimulated cells and relies on complex balance between multiple activators and inhibitors. We report here that c-mip, a recently identified pleckstrin homology (PH) and leucine-rich repeat (LRR)-domain-containing protein, inactivates GSKbeta and interacts with RelA, a key member of the NF-kappaB family. We show that c-mip inhibits the degradation of I-kappaBalpha and impedes the dissociation of the NF-kappaB/I-kappaBalpha complexes. C-mip acts downstream signaling of classical NF-kappaB pathway and may represent one of the missing links in the control of NF-kappaB activity.

PMID:
19019440
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk